Can GLP-1s Treat Cannabis Use Disorder
Kashin-Beck disease Kashin-Beck disease (KBD) is an endemic condition that affects an estimated 2.5 million people in Tibet, northern and central China, North Korea, and southeastern Siberia, a region of Russia (58)
Human clinical applications are unproven
This peptide, works by binding to melanocortin receptors and activating the melanin-producing cells in the skin, as demonstrated in various dermatological studies
How Genetic Insights Support Safe Treatment Decisions Individual variation in GLP-1 receptor function, metabolic enzymes, and lipid handling genes influences both efficacy and gastrointestinal tolerance
In addition, pairing fiber-rich foods and foods rich in healthy unsaturated fats with lean sources of protein can have a big impact on the bodys GLP-1 levels after meals 22,23